Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy

Absztrakt
Leírás
Kulcsszavak
Forrás
Journal of Translational Medicine. -17 (2019), p. 229. -J. Transl. Med. - 1479-5876